Abstract
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a chronic, complex multi-organ illness characterized by unexplained debilitating fatigue and post-exertional malaise (PEM). We evaluated transcriptomic changes in peripheral blood mononuclear cells (PBMC) of ME/CFS patients undergoing an exercise challenge and explored the transcriptomic response to exercise and recovery in PBMC of ME/CFS patients, as compared to healthy controls using RNA sequencing technology. As transcriptomic changes in ME/CFS patients are still in the phase of discovery, analysis of data has to be stringent, and the most important results have to be validated by a different technology, such as real-time PCR or NanoString.
| Original language | English |
|---|---|
| Title of host publication | Methods in Molecular Biology |
| Publisher | Humana Press Inc. |
| Pages | 103-112 |
| Number of pages | 10 |
| DOIs | |
| State | Published - 2025 |
Publication series
| Name | Methods in Molecular Biology |
|---|---|
| Volume | 2920 |
| ISSN (Print) | 1064-3745 |
| ISSN (Electronic) | 1940-6029 |
Bibliographical note
Publisher Copyright:© The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature 2025.
ASJC Scopus Subject Areas
- Molecular Biology
- Genetics
Keywords
- Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)
- Peripheral blood mononuclear cells (PBMC)
- RNA extraction
- RNA-seq data analysis
- Transcriptomics